| scholarly article | Q13442814 |
| P2093 | author name string | I Rodriguez | |
| B Volsky | |||
| D J Volsky | |||
| M Shahabuddin | |||
| G Bentsman | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors | Q28118386 | ||
| The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates | Q28282895 | ||
| HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists | Q28334629 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| The role of mononuclear phagocytes in HTLV-III/LAV infection | Q29618676 | ||
| Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease | Q33597345 | ||
| Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. | Q33685950 | ||
| Human immunodeficiency virus can productively infect cultured human glial cells | Q34625813 | ||
| In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. | Q35833638 | ||
| Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. | Q35837448 | ||
| Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation | Q35844026 | ||
| Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1. | Q35851143 | ||
| Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease | Q36232123 | ||
| Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures | Q36233456 | ||
| Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus | Q36244894 | ||
| Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes | Q36354762 | ||
| Neuropathology of Human Immunodeficiency Virus Infection | Q36476918 | ||
| Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes | Q36618922 | ||
| Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. | Q36633809 | ||
| Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line | Q36653358 | ||
| Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism | Q36656559 | ||
| Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. | Q36680591 | ||
| An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1 | Q36687524 | ||
| Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein | Q36687972 | ||
| Pathology of HIV-1 infection of the central nervous system. A review | Q36779458 | ||
| Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes | Q36796806 | ||
| Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells | Q36799015 | ||
| CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1 | Q36802755 | ||
| Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates | Q36811913 | ||
| Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta | Q36821418 | ||
| CD4-independent infection of human neural cells by human immunodeficiency virus type 1. | Q36828096 | ||
| Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
| Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual | Q36881607 | ||
| Infection of brain-derived cells with the human immunodeficiency virus | Q36886797 | ||
| Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. | Q36919950 | ||
| Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients | Q37400137 | ||
| Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes | Q37476959 | ||
| Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. | Q37577723 | ||
| The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex | Q39628230 | ||
| A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. | Q40041192 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome | Q40604776 | ||
| Analysis of glycoprotein-associated oligosaccharides | Q40835290 | ||
| HIV-1 infection of primary human neuroblasts | Q41334203 | ||
| Infection of human fetal astrocytes with HIV-1: viral tropism and the role of cell to cell contact in viral transmission. | Q41348657 | ||
| HIV-1 Infection of Human Brain-Derived Microvascular Endothelial Cells In Vitro | Q41350235 | ||
| HIV type 1 infection of human cortical neuronal cells: enhancement by select neuronal growth factors | Q41419650 | ||
| Restricted expression of HIV1 in human astrocytes: molecular basis for viral persistence in the CNS. | Q41471863 | ||
| T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 gp160, like Kex2p endoprotease, is a calcium-dependent enzyme. | Q41504435 | ||
| Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization. | Q41546951 | ||
| Human cortical neuronal cell line: a model for HIV-1 infection in an immature neuronal system | Q41557312 | ||
| Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines | Q41637702 | ||
| A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation | Q41651591 | ||
| Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide | Q41674152 | ||
| Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway | Q41680992 | ||
| Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus | Q41690309 | ||
| HIV-1 propagates in human neuroblastoma cells | Q41706878 | ||
| Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. | Q41710744 | ||
| Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus | Q41876028 | ||
| Progressive encephalopathy in children with acquired immune deficiency syndrome | Q41933992 | ||
| Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction | Q41979543 | ||
| Regulated expression of human immunodeficiency virus type 1 in human glial cells: induction of dormant virus | Q42455241 | ||
| AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations | Q42478988 | ||
| Maintenance of human immunodeficiency virus type-1 proviral DNA in human fetal dorsal root ganglia neural cells following a nonproductive infection | Q43587569 | ||
| The AIDS dementia complex: I. Clinical features | Q43769670 | ||
| High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients | Q44019946 | ||
| PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy | Q44031760 | ||
| Biological characterization of noninfectious HIV-1 particles lacking the envelope protein | Q44174193 | ||
| Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry | Q44303304 | ||
| HIV and the brain: evidence of early involvement and progressive damage. | Q44943521 | ||
| Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing | Q45252128 | ||
| The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection | Q45829270 | ||
| Human immunodeficiency virus infection of the developing human nervous system | Q45830152 | ||
| Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis | Q45830244 | ||
| A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV). | Q45831260 | ||
| Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene | Q45834667 | ||
| Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy | Q45836320 | ||
| Human immunodeficiency virus replication in human brain cells. Brief report | Q45847681 | ||
| Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. A quantitative kinetic study | Q45859981 | ||
| HIV-1 infection of subcortical astrocytes in the pediatric central nervous system | Q48162348 | ||
| Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues | Q48162358 | ||
| Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). | Q48381924 | ||
| Multinucleated giant cells and HTLV-III in AIDS encephalopathy | Q48467895 | ||
| HTLV-III infection in brains of children and adults with AIDS encephalopathy | Q48536178 | ||
| Specific tropism of HIV-1 for microglial cells in primary human brain cultures | Q48920198 | ||
| Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. | Q52206264 | ||
| Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. | Q55485619 | ||
| Human immunodeficiency virus and the central nervous system | Q67587480 | ||
| Persistent inapparent HIV-1 infection of human neuroblastoma cells | Q68068077 | ||
| Generation of a new gamma delta T cell-specific monoclonal antibody (GD3.5). Biochemical comparisons of GD3.5 antigen with the previously described Workshop Cluster 1 (WC1) family | Q71059412 | ||
| Biochemical and genetic definition of the cellular protease required for HIV-1 gp160 processing | Q72536424 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7992-8002 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells | |
| P478 | volume | 70 |
| Q33819734 | Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes |
| Q28246676 | Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis |
| Q39598680 | Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes |
| Q35020221 | Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro |
| Q33853536 | Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes |
| Q35857775 | Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway |
| Q34589369 | Insights into the role of immune activation in HIV neuropathogenesis |
Search more.